细胞外囊泡封装的半孔性分子印记,用于类药物输送
Meixin Wang1, Xingguo Liu1, Jingyuan Song1
1School of Life Sciences, Jilin University, Changchun 130012, China.
Colloids and surfaces. B, Biointerfaces
|July 24, 2025
概括
一个新的仿生纳米输送系统 (EV@DhHP-6-MIP) 结合了细胞外囊泡和印制的来保护和输送抗氧化. 这个系统增强了的稳定性和生物可用性,减少了细胞中的氧化应激,并延长了模型生物的寿命.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 药物输送系统 药物输送系统
背景情况:
- 类疗法在代谢障碍,癌症和传染病方面表现有前途.
- 由于的快速降解和细胞透性差,临床使用受到限制.
- 现有的合成载体可能会导致免疫性问题.
研究的目的:
- 开发一个仿生纳米输送系统 (EV@DhHP-6-MIP) 来增强类药物输送.
- 克服酸降解和跨膜透性的局限性.
- 为了利用牛奶衍生的细胞外囊泡 (EVs) 和分子印记的半孔.
主要方法:
- 超声波辅助膜融合技术将乳制品EV与分子印制的半孔结合起来.
- 带有印记结合点的半孔酸盐促进了DhHP-6的高效加载.
- 通过受体依赖性内细胞分裂,EVs通过受体依赖性内细胞分裂调解了向传递,从而最大限度地降低了免疫性.
主要成果:
- 在人类胚胎脏293T细胞中,EV@DhHP-6-MIP使细胞内ROS水平降低了38.5%.
- 在Caenorhabditis elegans中,治疗在氧化应激下延长了31.2%的存活时间.
- 肠道利波素积累量减少了40.47%,没有产生生殖毒性.
结论:
- 该EV@DhHP-6-MIP系统有效地稳定,控制释放,并增强交付.
- 这种三方协同机制克服了类药物输送方面的挑战.
- 开发的系统为开发有效,低毒性纳米药物输送系统提供了一个有希望的范式.
相关概念视频
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


